Biologics/Immunotherapy News

Severe reactions during home oral immunotherapy were rare, and milk OIT, asthma and sensitization to house dust mite were the main risk factors, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Black patients and those on Medicaid had lower rates of adherence to biologics prescribed for asthma, often due to patient-level barriers, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Healio compiled the most-read news in allergy, asthma and immunology posted in April.

SAN DIEGO — A reimagined approach to uncontrolled severe asthma is needed amid poor diagnosis and management trends, according to Samuel Louie, MD, a professor of medicine at the University of California, Davis.

Only about one-third of patients adhered to their course of maintenance doses in their subcutaneous immunotherapy even when there were no out-of-pocket expenses, according to a study published in Annals of Allergy, Asthma & Immunology.

Most patients who developed eosinophilic esophagitis during oral immunotherapy experienced resolution in their EoE symptoms without stopping OIT, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Black and Hispanic patients with allergic rhinitis get fewer prescriptions for subcutaneous immunotherapy compared with white patients, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Fractional exhaled nitric oxide levels predicted treatment response to dupilumab among patients who had uncontrolled moderate to severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Sublingual immunotherapy for peanut allergy was safe and effective among children aged 2 to 12 years, making it a promising alternative to oral immunotherapy, according to a study published in The Journal of Allergy and Clinical Immunology.

OIT for tree nut allergies was safe and tolerable among a preschool population with results comparable to OIT for peanut allergy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.